CClinicalTrials.gg
RecruitingNCT06902636Updated Aug 6, 2026

Geriatric Trauma Care Program for Living Alone Older Adults With Injuries

An interventional study of Geriatric trauma care program in Limb Injury, Older Adults and Geriatric, sponsored by Kaohsiung Medical University. Recruiting at 1 site in Taiwan. Open to participants aged 65 Years and older. Per ClinicalTrials.gov, last updated 2026-08-06.

Sponsored by Kaohsiung Medical University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Started Mar 2025; still recruiting 1 year 6 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
90
Allocation
Randomized
Ages
65 Years and older
Sex
All
01

Study summary

To examine the long-term effects of the Geriatric Trauma Care Program (GTCP) regarding pain, functional disability, depression, loneliness, and health-related quality of life among older adults with traumatic injuries who live alone.

Read the detailed description

Traumatic injuries among older adults represent a significant public health concern due to their potential to severely affect individuals' long-term physical, emotional, and social well-being. Older adults who experience traumatic injuries often face substantial challenges during recovery, particularly those living alone who may lack sufficient support systems, exacerbating their vulnerability to chronic health issues. Pain, functional disability, depression, loneliness, and diminished health-related quality of life are prevalent adverse outcomes following traumatic injuries, underscoring the critical need for effective, targeted care strategies to address these multidimensional impacts.

The Geriatric Trauma Care Program (GTCP) is a nurse practitioner-led, digitalized trauma care program designed to provide comprehensive and accessible intervention aimed at improving immediate trauma care outcomes and facilitating sustainable recovery among older adults. While short-term benefits of digitally supported, geriatric-focused trauma interventions have been documented, the long-term effectiveness of such programs, especially for older individuals who live alone, remains less understood. Consequently, examining the enduring impact of the GTCP is essential to determine its effectiveness in fostering sustained recovery and improving quality of life for this vulnerable population. This study aims to address this gap by evaluating the long-term effects of the GTCP on pain, functional disability, depression, loneliness, and health-related quality of life among older adults with traumatic injuries who live alone. Findings from this research will provide valuable insights for healthcare providers and policymakers to enhance care delivery models, optimize resource allocation, and ultimately improve long-term outcomes for older adults recovering from traumatic injuries.

02

Conditions studied

  • Limb Injury
  • Older Adults
  • Geriatric
  • Pain
  • Geriatric Depression
  • Barthel Index
  • Quality of Life
  • Loneliness

Browse trials for

Keywords

  • Limb injury
  • geriatric trauma
  • older adults
  • loneliness
03

In context

Pain

2,219 studies on the registry are indexed under Pain; 917 are open to participants now.

This study's planned enrollment of 90 is above the median of 70 across 1,904 interventional studies indexed under Pain.

Browse Pain studies →

Lead sponsor

Kaohsiung Medical University is the lead sponsor of 55 studies on the registry; 16 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
65 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  1. willing to join this study for three months
  2. with limb injuries
  3. living alone in a household
  4. aged 65 years old or older
  5. independent before a traumatic injury
  6. having a smartphone.

Exclusion criteria

Exclusion Criteria:

  1. with an ISS greater than 16 (severe injuries)
  2. having cognitive impairments
  3. diagnosed with psychiatric illness
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Investigator)
Enrollment
90 participants (estimated)

Study arms

  • No intervention
    Control group

    The control group will have the routine care only

  • Experimental
    Geriatric Trauma Care Program

    The experiment group will implement the Geriatric Trauma Care Program (GTCP) and routine care. The GTCP will be implemented through an E-book that includes six units of intervention for older adults with traumatic injuries who live alone.

    Behavioral: Geriatric trauma care program

Interventions

  • BehavioralGeriatric trauma care program

    The experiment group will implement the Geriatric trauma care program (GTCP) and routine care. The GTCP will be implemented by a nurse practitioner and equipped with digitalized educational material, including six units of intervention for older adults with traumatic injuries who live alone.

06

What researchers measure

Primary outcomes

  1. Pain intensity

    Measured by the Numeric Pain Rating Scale with the numbers 0-10, with 0 meaning no pain and 10 meaning the worst pain.

    Time frame: Day 1 at Hospital discharge, 1 month, and 3 months

  2. Functional disability

    The Barthel's Index consists of 30 items, ranging from 0 to 100, with higher scores indicating greater functional capacity.

    Time frame: Day 1 at Hospital discharge, 1 month, and 3 months

  3. Depression

    The Geriatric Depression Scale Short Form, which comprises 15 items scored on a two-point scale (0 = no, 1 = yes). It scores ranged from 0-15 with the higher indicated the more severe depression symptoms.

    Time frame: Day 1 at Hospital discharge, 1 month, and 3 months

  4. Loneliness

    The Elderly Loneliness Scale has eight items, with a higher score indicating more loneliness.

    Time frame: Day 1 at Hospital discharge, 1 month, and 3 months

  5. Health-related quality of life

    The EuroQol-5D has five items with higher score indicated a worse health condition.

    Time frame: Day 1 at Hospital discharge, 1 month, and 3 months

07

Study locations

1 of 1 sites recruiting
  • Kaohsiung Medical University Chung Ho Memorial Hospital
    Kaohsiung City, Kaohsiung 807, Taiwan
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 6, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06902636
Lead sponsor
Kaohsiung Medical University
Collaborators
National Science and Technology Council, Taiwan
Responsible party
Santo Imanuel Tonapa (Principal investigator, Kaohsiung Medical University) — Principal investigator
First posted
Mar 30, 2025
Start date
Mar 27, 2025
Primary completion
Oct 31, 2026 (estimated)
Completion
Oct 31, 2026 (estimated)
Last update
Aug 6, 2026

Study contacts

Bih-O Lee, PhD
Contact
biholee@kmu.edu.tw
07-3121101 ext. 2625
Santo Imanuel Tonapa, PhD
Contact
i.santonapa@gmail.com
0981979212
Bih-O Lee, PhD
principal investigator · College of Nursing, Kaohsiung Medical University

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion